指南与共识MDS 与骨髓增殖性肿瘤白血病

国际共识分类与第五版世界卫生组织分类在成人骨髓增生异常综合征和急性髓系白血病中的比较

Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
指南 / 共识 · Am J Hematol · 2023-01-05

该文比较国际共识分类(ICC)与第五版世界卫生组织分类(WHO-HAEM5)在成人骨髓增生异常综合征/肿瘤(MDS)和急性髓系白血病(AML)中的诊断标准和实体定义,旨在为病理学家、血液学家和研究人员提供工具。

要点

  • ICC与WHO-HAEM5是近期提出的两个髓系肿瘤分类方案。
  • 文章聚焦于成人MDS和AML的诊断标准与实体定义比较。
  • 目标是为诊断和治疗相关血液恶性肿瘤的从业者提供参考工具。

核心结论

  • 本文回顾并比较了ICC与WHO-HAEM5在成人MDS和AML中的诊断标准和实体定义,以促进病理学家、血液学家和研究人员的诊断与治疗工作。

研究设计与样本

  • 本文为综述,比较国际共识分类(ICC)与第五版世界卫生组织分类(WHO-HAEM5)在成人骨髓增生异常综合征/肿瘤(MDS)和急性髓系白血病(AML)中的诊断标准与实体定义。

主要发现

  • 自第四版WHO分类(WHO-HAEM4)以来,髓系肿瘤领域在临床病理、免疫表型和分子方面的进展促进了诊断标准的细化、临时性实体的升级和新实体的识别。
  • 这些进展导致了两个新的髓系肿瘤分类方案的提出:国际共识分类(ICC)和第五版WHO分类(WHO-HAEM5)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several editions of the World Health Organization (WHO) classifications of lympho-hemopoietic neoplasms in 2001, 2008, and 2016 served as the international standard for diagnosis. Since the 4th WHO edition, here referred as WHO-HAEM4, significant clinico-pathological, immunophenotypic, and molecular advances have been made in the field of myeloid neoplasms, which have contributed to refine diagnostic criteria, to upgrade entities previously defined as provisional and to identify new entities. This process has resulted in two recent classification proposals of myeloid neoplasms: the International Consensus Classification (ICC) and the 5th edition of the WHO classification (WHO-HAEM5). In this paper, we review and compare the two classifications in terms of diagnostic criteria and entity definition, with a focus on adult myelodysplastic syndromes/neoplasms (MDS) and acute myeloid leukemia (AML). The goal is to provide a tool to facilitate the work of pathologists, hematologists and researchers involved in the diagnosis and treatment of these hematological malignancies.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Falini B, Martelli MP. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia. Am J Hematol. 2023. PMID: 36606297. doi:10.1002/ajh.26812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。